2022-02-17T19:27:38Z
2022-02-17T19:27:38Z
2010-03-10
2022-02-17T19:27:38Z
Death receptor 3 is a proinflammatory member of the immunomodulatory tumor necrosis factor receptor superfamily, which has been implicated in several inflammatory diseases such as arthritis and inflammatory bowel disease. Intriguingly however, constitutive DR3 expression has been detected in the brains of mice, rats, and humans, although its neurological function remains unknown. By mapping the normal brain expression pattern of DR3, we found that DR3 is expressed specifically by cells of the neuron lineage in a developmentally regulated and region-specific pattern. Behavioral studies on DR3-deficient (DR3(ko)) mice showed that constitutive neuronal DR3 expression was required for stable motor control function in the aging adult. DR3(ko) mice progressively developed behavioral defects characterized by altered gait, dyskinesia, and hyperactivity, which were associated with elevated dopamine and lower serotonin levels in the striatum. Importantly, retrograde tracing showed that absence of DR3 expression led to the loss of corticostriatal innervation without significant neuronal loss in aged DR3(ko) mice. These studies indicate that DR3 plays a key nonredundant role in the retention of normal motor control function during aging in mice and implicate DR3 in progressive neurological disease.
Article
Versió publicada
Anglès
Inflamació; Malalties neurodegeneratives; Envelliment cerebral; Inflammation; Neurodegenerative Diseases; Aging brain
The Society for Neuroscience
Reproducció del document publicat a: https://doi.org/10.1523/JNEUROSCI.1928-09.2010
Journal of Neuroscience, 2010, vol. 30, num. 10, p. 3782-3792
https://doi.org/10.1523/JNEUROSCI.1928-09.2010
info:eu-repo/grantAgreement/EC/FP7/222918/EU//REPLACES
cc-by-nc-sa (c) Twohig, Jason Peter et al., 2010
https://creativecommons.org/licenses/by-nc-sa/4.0/